COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,554 Articles (22,400 medRxiv, 8,154 bioRxiv)

Most recent first Previous |  Page 2827: Articles 28261-28270  | Next

Estimating Survival of Hospitalized COVID-19 Patients from Admission Information
Levy, T. J., Richardson, S., Coppa, K., Barnaby, D. P., McGinn, T., Becker, L. B., Davidson, K. W., Hirsch, J. S., Zanos, T., Northwell COVID-19 Research Consortium
10.1101/2020.04.22.20075416 — Posted: 2020-04-27
Eosinopenia Phenotype in Patients with Coronavirus Disease 2019: A Multi-center Retrospective Study from Anhui, China
Cheng, Y., Zhou, Y., Zhu, M., Zha, L., Lu, Z., Ding, Z., Yang, J., Yang, G.
10.1101/2020.04.22.20071050 — Posted: 2020-04-27 Discussion: Onsite
Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories
Lieberman, J., Pepper, G., Naccache, S. N., Huang, M., Jerome, K. R., Greninger, A. L.
10.1101/2020.04.24.20074559 — Posted: 2020-04-27
Estimating population immunity without serological testing
Lesniewski, A.
10.1101/2020.04.23.20076786 — Posted: 2020-04-26
ICU and ventilator mortality among critically ill adults with COVID-19
Auld, S., Caridi-Scheible, M., Blum, J. M., Robichaux, C. J., Kraft, C. S., Jacob, J. T., Jabaley, C. S., Carpenter, D., Kaplow, R., Hernandez, A. C., Adelman, M. W., Martin, G. S., Coopersmith, C. M., Murphy, D. J., Emory COVID-19 Quality and Clinical Research Collaborative
10.1101/2020.04.23.20076737 — Posted: 2020-04-26
A systematic review of Anakinra, Tocilizumab, Sarilumab and Siltuximab for coronavirus-related infections
Khan, F., Fabbri, L., Stewart, I., Robinson, K., Smyth, A. R., Jenkins, G.
10.1101/2020.04.23.20076612 — Posted: 2020-04-26
How did SARS-CoV-19 spread in India from Italy, Iran and China? Genetic surveillance of early cases and virus demography
Thakur, M., Singh, A., Joshi, B. D., Ghosh, A., Singh, S. K., Singh, N., Sharma, L. K., Chandra, K.
10.1101/2020.04.26.062406 — Posted: 2020-04-26 Discussion: Onsite
Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus
Viswanathan, T., Arya, S., Chan, S.-H., Qi, S., Dai, N., Hromas, R. A., Park, J.-G., Oladunni, F., Martinez-Sobrido, L., Gupta, Y. K.
10.1101/2020.04.26.061705 — Posted: 2020-04-26
Open Access and Altmetrics in the pandemic age: Forescast analysis on COVID-19 related literature
Torres-Salinas, D., Robinson-Garcia, N., Castillo-Valdivieso, P. A.
10.1101/2020.04.23.057307 — Posted: 2020-04-26
Characterization of intra-host SARS-CoV-2 variants improves phylogenomic reconstruction and may reveal functionally convergent mutations
Ramazzotti, D., Angaroni, F., Maspero, D., Gambacorti-Passerini, C., Antoniotti, M., Graudenzi, A., Piazza, R.
10.1101/2020.04.22.044404 — Posted: 2020-04-26 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).